Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126925014 | 12692501 | 4 | F | 20160823 | 20160829 | 20160906 | EXP | GB-MHRA-EYC 00143694 | GB-CIPLA LTD.-2016GB17746 | CIPLA | 0.00 | Y | 0.00000 | 20160906 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126925014 | 12692501 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, QD | Y | U | 77073 | 10 | MG | QD | |||||
| 126925014 | 12692501 | 2 | SS | Perindopril | PERINDOPRIL | 1 | Oral | 8 MG, QD | Y | U | 0 | 8 | MG | QD | |||||
| 126925014 | 12692501 | 3 | SS | Amitriptyline | AMITRIPTYLINE | 1 | Oral | 20 MG, QD, AT NIGHT | Y | U | 0 | 20 | MG | QD | |||||
| 126925014 | 12692501 | 4 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG, QD | Y | U | 0 | 25 | MG | QD | |||||
| 126925014 | 12692501 | 5 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126925014 | 12692501 | 6 | C | Atorvastatin | ATORVASTATIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126925014 | 12692501 | 7 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126925014 | 12692501 | 8 | C | Codeine | CODEINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126925014 | 12692501 | 9 | C | GLYCERYL TRINITRATE | NITROGLYCERIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126925014 | 12692501 | 10 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126925014 | 12692501 | 11 | C | Loperamide | LOPERAMIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126925014 | 12692501 | 12 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126925014 | 12692501 | 13 | C | Paracetamol | ACETAMINOPHEN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126925014 | 12692501 | 14 | C | Quinine | QUININE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126925014 | 12692501 | 15 | C | Salbutamol | ALBUTEROL | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126925014 | 12692501 | 16 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126925014 | 12692501 | 17 | C | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126925014 | 12692501 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126925014 | 12692501 | Orthostatic hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |